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ABSTRACT
Phytoestrogens are plant chemicals that have been related to the occurrence of human breast cancers and other estrogen-dependent
cancers. This study was designed to examine the potential combinational effects and estrogenic activity of phytoestrogens in MCF-7
human breast cancer cells. Results showed that the phytoestrogens biochanin A and daidzein inhibited the proliferation of MCF-7 cells
in a dose-dependent manner. Both biochanin A and daidzein delayed the progression of the cell cycle from the G2/M phase to the G1
phase at growth inhibitory concentrations. Treatment with biochanin A down-regulated the level of estrogen receptor-alpha (ER-α)
mRNA, but this down-regulation was not affected by the presence of the antiestrogen ICI182,780. When cells were treated with
biochanin A at a growth inhibitory concentration of 40 µg/mL, co-administration of daidzein resulted in an enhanced inhibitory effect
on the MCF-7 cell growth. In addition, neither the growth inhibition, nor the delayed cell cycle progression induced by biochanin A
was affected by the addition of antiestrogen. These results suggest that the growth regulatory effects of phytoestrogens may be associated with cell cycle progression, and the underlying mechanism involves at least in part the modulation of a non-classical ER-α signal
pathway.
Key words: phytoestrogen, fertility, estrogen receptor

INTRODUCTION
Phytoestrogens are natural plant substances that are
present in certain plants and foliage including soybeans,
alfalfa and citrus plants. They can occur in high concentrations (up to 5% dry mass) in clover, especially Trifolium
subterraneum (subterranean clover), T. pratense (red
clover) and closely related species. The presence of these
chemicals has been proposed as having an important
influence on ruminant fertility (1). Phytoestrogens share
structural similarity to natural animal estrogens, such as
estradiol, and exhibit affinity for the estrogen receptor(2,3,4).
These compounds have been considered to be responsible
for the depression of fertility observed in sheep grazing in
clover pasture(5). Phytoestrogens were also implicated in
bovine infertility(6).
It has been shown that phytoestrogens in soybeans are
metabolized in the digestive tract and can be detected in
urine and plasma (7,8,9). Recently, phytoestrogens have
drawn much attention because of their possible cancer-preventing effects (10,11) and their ability to reduce the
incidence of breast cancer in animals (12,13) . Epidemiological data suggest that a diet rich in phytoestrogens
* Author for correspondence. Tel: +886-2-28819471 ext. 6858;
Fax: +886-2-28831193; E-mail: cying@mail.scu.edu.tw

decreases the risk of breast cancer(14). Women on traditional Asian low-fat, high-soy diet were found to have a lower
risk of developing breast cancer and estrogen deficiency
diseases such as heart disease and osteoporosis, than
women on western diets. Such marked differences between
women with Asian and Western diets are not due to genetic
factors but are more likely dietary(15).
Daidzein, a hydroxylated isoflavone and biochanin A,
the 4’-methyl ethers of genistein(16) are two important phytoestrogens in major pasture legumes Trifolium subterraneum (subterranean clover), and T. pratense (red clover)
and in soybeans (up to 100-300 µ g/100 g)(17). In vitro
studies showed that daidzein exhibits low but measurable
binding affinity to both subtypes of estrogen receptor (ER)
proteins ER-α and ER-β while biochanin A has very little
affinity for either subtype(3,18,19,20). Previous studies also
showed that biochanin A or daidzein alone inhibited cell
proliferation and DNA synthesis in several cancer cell
lines(21,22,23). Analysis of serum or urine in human revealed
the presence of multiple phytoestrogens suggesting that
phytoestrogens may act cumulatively(24). However, studies
on the combinational effects of phytoestrogens on cell
growth and their estrogenic activity on ER have been rather
limited or controversial(25,26,27). In this study, we investigated not only the individual but also the combined growth
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regulatory effects of daidzein and biochanin A using an
estrogen model system, the human breast cancer cells. We
also analyzed the effects of phytoestrogens on cell cycle
progression in this model system. Lastly we showed that
biochanin A regulated the level of ER- α mRNA and
continued to exert its regulatory effects even in the presence
of an antiestrogen ICI182,780.

MATERIALS AND METHODS
I. Chemicals
Biochanin A and daidzein were purchased from Sigma
Chemical Co. (St. Louis, MO, USA) and Research
Biochemicals International (Natick, MA, USA), respectively. Solutions of biochanin A and daidzein were prepared in
dimethylsulphoxide (DMSO) and stored at -20˚C in the
dark.
II. Cell Culture Conditions
MCF-7 human breast cancer cells were grown in
phenol red-free DMEM supplemented with either 10% fetal
bovine serum (FBS) or 3X dextran/charcoal stripped FBS
(DC-FBS). Cultures were maintained at 37˚C in a humidified atmosphere of air/CO2 (95/5) and fed every other day.
III. Cell Proliferation Assays
Cells were first cultured in DMEM medium supplemented with 10% FBS until they reached confluence.
These cells were cultured for another 24 hr in DMEM
medium. Cells were then collected by trypsinization,
counted and seeded in culture flasks or 96-well culture
plates in medium containing 10% DC-FBS. After culturing
for 24 hr to ensure attachment of cells, medium was
removed and fresh medium supplemented with 10% DCFBS alone or with test concentrations of phytoestrogen was
then added. DMSO was added to the same dilution (0.1%,
v/v) in all samples. The cells were then incubated at 37˚C.
For cell grown in culture flasks, the number of viable cells
in each sample was determined by trypan blue dye
exclusion assay in which viable cells remain transparent,
whereas non-viable cells appear blue under the microscope.
Cell proliferation for cells grown in 96-well plates was
determined by using mitochondrial activity assays as
described previously(28,29,30). In particular, the WST-1 colorimetric assay kits (Boehringer Mannheim UK Ltd, Bell
Lane, East Sussex, UK) was used in accordance with the
manufacturer's instructions. This kind of assay, which
considers metabolic activity to be an index for cell proliferation is similar to those assays using other tetrazolium salt,
3-(4,5-dimethylthiszol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), to determine cell proliferation(29,30). The
absorbance at 450 nm (formazan dye) and 650 nm (cellular
background) was measured individually for each well after

the addition of WST-1 reagent. Subtracting the absorbance
at 650 nm from the absorbance at 450 nm then gives an
index that is directly correlated to the cell number in each
well(31).
IV. Cell Cycle Analysis
A previously established procedure(32) was used to
analyze the cell cycle distribution of MCF-7 cells treated
with biochanin A or daidzein. In summary, cells were
grown to confluence in a medium containing 10% FBS.
The medium was then removed and cells were cultured in
medium containing no serum for another 24 hr. Cells were
collected and reseeded in medium containing DC-FBS for
24 hr prior the addition of tested chemicals. After
treatment, the cells were washed twice with PBS and
suspended in phosphate-buffered NaCl solution (PBS) containing 50 mg/mL propidium iodide, 0.1% sodium citrate
and 0.1% Triton X-100 at the density of 1 × 106/mL. Cells
were then incubated overnight at 4˚C in the dark and
analyzed with flow cytometry (Epics Elite ESP XL,
Coulter). Each analysis was repeated at least twice.
V. Reverse-Transcriptase Polymerase Chain Reaction (RTPCR)
Total RNA from MCF-7 cells treated with biochanin A
alone or with ICI182,780 for 2 days were prepared as
described by Hsu et al.(31). The RT reaction was performed
using 0.1-0.2 µL of total RNA in a 20-µL reaction mixture.
A portion of the RT product containing an equal amount of
cDNA from each sample was then subjected to PCR. The
PCR reaction mixture contained 2 µL of 10X PCR buffer,
1.6 µL of 50 µM MgCl2, 11.7 µL of DEPC-treated water,
1.5 µL of RT-reaction mixture, 1 µL of 10 mM dNTPs, l
unit of Taq DNA polymerase, and 2 µ L of ER-alpha
primers (5’-GGAGATTCTGATGATTGGTCT-3’ and 5’CATCTCCAGGAGCAGGTCAT-3’; 250 µ g/mL) or
ribosomal protein L19 (RPL19) primers (5'-CTGAAGGTCAAAGGGAATGTG-3’ and 5’-GGACAGAGTCTTGATGATCTC-3’; 125 µg/mL). The RPL19 is constitutively
expressed and used as a control for the RT-PCR reaction(33).
The ER-alpha and RPL19 cDNA fragments were
amplified by standard PCR procedure (35 cycles; 94˚C/1
min, 60˚C/1 min, 72˚C/1 min). The 477 base pairs (bp) and
194 bp amplified product for ER-alpha and RPL19, respectively, was fractionated on 2% agarose gel and stained with
ethidium bromide.
IV. Statistical Analysis
The method of least squares ANOVA was used for
data analysis(34,35). The means of treatment were compared
by the orthogonal contrast with the comparisons of each
individual treatment vs. control blank.
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RESULTS
I. The Effects of Daidzein and Biochanin A on the Cell
Proliferation of MCF-7 Cells
Both biochanin A and daidzein showed biphasic regulation effects on the cell proliferation of MCF-7 cells
(Figure 1). Low concentrations (<10 µg/mL) of daidzein or
biochanin A stimulated cell proliferation while cell proliferation was inhibited at higher concentrations. This observation agrees well with studies previously reported in T-47D
and other human breast cancer cells(21,27). Limited cell
death was observed at 40 µg/mL biochanin A or 50 µg/mL
daidzein as determined by trypan blue dye exclusion assay.
The number of viable cells after the treatment of 40 µg/mL
biochanin A was comparable with the starting cell number.
This observation suggested that biochanin A at this concentration range did not cause significant cell death and the
observed decline in the number of viable cells was probably
due to cell growth inhibition. Previous study also showed
that altered cell permeability of MCF-7 cells determined by
the release of lactate dehydrogenase was observed
primaring at higher concentrations (>80 µ g/mL) of
biochanin A(21). Therefore, although one cannot completely rule out the possibility that the effects seen at higher concentrations (50 µ g/mL for daidzein and 40 µ g/mL for
biochanin A) are due to cytotoxicity of the tested phytoe140
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strogen since detailed cytotoxic assays were not performed,
the cytotoxic effects were expected to be minimal or
limited. At higher concentrations of phytoestrogens (>75
µ g/mL for daidzein and >60 µ g/mL for biochanin A),
however, cells became detached and floated in the culture
and the majority of the floating cells appeared non-viable
(data not shown).
In the presence of a growth-inhibitory concentration of
biochanin A (40 µg/mL), co-administration of various concentrations of daidzein (5-75 µg/mL) produced an enhanced
growth regulatory effect (Figure 2A, Figure 3A). For
example, cell proliferation was inhibited by 72.4% when
both biochanin A (40 µg/mL) and daidzein (75 µg/mL)
were present as compared to a 43.5% and a 56.5% inhibition by biochanin A or daidzein alone at the same concentrations, respectively (Figure 2A). At lower concentrations
of biochanin A (5-20 µg/mL), the effects of co-administrated daidzein appeared to mask the effect of biochanin A and
no synergistic effects was detected (Figure 2B, C and D,
Figure 3B).
II. Cell Cycle Progression of Daidzein- and Biochanin Atreated MCF-7 Cells
Figure 4 shows the distribution of the MCF-7 cell
cycle phases after treatment with daidzein or biochanin A
for different times. In the controls (Figure 4), the percentage of MCF-7 cells in the S and G2/M phases peaked at 6
and 12 hr, respectively. At 24 hr, more than half of the
control cells previously in the G2/M phase reentered the G1
phase. In contrast, for cells treated with daidzein, the S and
G2/M populations were the highest at 12 and 24 hr, respectively. Most of the daidzein-treated cells did not re-enter the
G1 phase until 48 hr. Thus treatment with daidzein
evidently prolonged the cell cycle by delaying progression
from one cell cycle phase to the next. There was no significant build-up in the G1 phase, that indicates blockage in the
G1 to S transition, was observed in any of the treatment
(Figure 4). Biochanin A also delayed the cell cycle progression in MCF-7 cells (Figure 4). Cells treated with
biochanin A accumulated at the G2/M phase and reentered
the G1 phase very slowly. Biochanin A also caused cells at
the S phase to progress into the G2/M phase more slowly
than the control cells (Figure 4).
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Figure 1. The growth regulation of MCF-7 human breast cancer cells
by biochanin A and daidzein. (A) MCF-7 cells seeded in 96 well
plates were cultured in DMEM containing 10% DC-FBS for the
indicated period of time and the number of viable cells was determined. (B) Cells were incubated with biochanin A or daidzein for 2
days and the number of viable cells was determined by WST-1 assay
as described in the Materials and methods. The number of viable
cells after grown for 2 days in control vehicle was designated 100%.
The * indicates a significant difference (p < 0.05) with respect to the
control value. Data are the mean of five replications and similar
experiment was performed at least twice.

III. The Effects of Antiestrogen on the Biochanin A Induced
Cell Growth Inhibition, Cell Cycle Progression and the
Level of ER-α mRNA
The addition of antiestrogen ICI182,780 did not block
the growth inhibition induced by biochanin A in MCF-7
cells (Figure 5A). Cell cycle analysis revealed that the
delay in cell cycle progression caused by biochanin A was
likewise not affected by the presence of the antiestrogen
(Table 1). The level of ER-α mRNA was down-regulated
by the growth-inhibitory concentration of biochanin A
(Figure 5B). This down-regulation was not significantly
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Figure 2. Combined growth regulation effect on MCF-7 cells. (A)-(D). MCF-7 cells were incubated with biochanin A at 40, 20, 10 or 5
µg/mL, respectively, for 4 days in the presence of indicated concentrations of daidzein. Cell proliferation was measured using the WST-1 assay.
Values are mean ± SD (n=5). Significant differences (p < 0.05) compared to the 0.1% DMSO vehicle-treated samples control, to biochanin A
treatment alone, to daidzein treatment alone at the same concentrations are indicated by an asterisk (*), a pound sign (#) and a percentage sign
(%), respectively.

Table 1. Cell cycle progression of MCF-7 cells treated with
biochanin A and antiestrogen ICI182,780
Percentage of cells (%)
Time Treatmenta
G1/G0
S
G2/M
0 hr
79.6 ± 2.0
17.7 ± 0.4
2.6 ± 2.6
73.2 ± 9.9
12.9 ± 7.7
9.0 ± 7.1
24 hr Controlb
BioA
53.9 ± 5.5
41.4 ± 3.2
4.8 ± 2.4
BioA + ICI
63.7 ± 0.9
35.6 ± 1.6
0.7 ± 0.7
48 hr Control
68.1 ± 7.9
27.4 ± 6.1
3.9 ± 2.3
BioA
69.4 ± 2.0
13.6 ± 3.6
17.1 ± 1.5
BioA + ICI
57.9 ± 12.4
33.0 ± 12.6
9.1 ± 0.2
a
MCF-7 cells were treated with 40 µg/mL biochanin A alone (bioA)
or simultaneously with 40 µg/mL ICI182,780 (bioA+ICI) for 0-48 hr
and the percentages of cells at each phase of the cell cycle were
analyzed (mean ± SEM, n = 2).
b
vehicle.

blocked by the co-administrated ICI182,780 although the
mRNA level of ER-α did appear to decline somewhat in
cells treated with ICI182,780 alone. These results thus
suggest that the growth inhibition induced by biochanin A
is not mediated through the classical ER-α dependent
pathway(s) in MCF-7 cells at the tested concentration.
Although previous reports(18,20,36) indicated that the effects
of phytoestrogens could be mediated through another
subtype of ER protein, ER-β, it was difficult to determine
the potential effects of biochanin A on ER-β in this cell line
since the levels of ER-β mRNA in MCF-7 cells were below
our RT-PCR detection limit. Other investigators also
reported the lack of ER-β expression in MCF-7 cells(37,38).
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In this study, we examined the growth regulatory
effects of two phytoestrogens, daidzein and biochanin A in
the model system for estrogen response, the MCF-7 cells.
In agreement with previous studies, the inhibition of cell
growth was dose-dependent, while growth stimulation was
observed at low concentrations of both phytoestrogens. At
growth inhibitory concentrations, however, the cell cycle
progression of daidzein-treated MCF-7 cells was altered
such there was an extended period of time before cells
entered the G2/M phase from the S phase. Biochanin A
showed similar effects on the cell cycle progression in
MCF-7 cells. These results suggested that cell cycle regulation might be involved in the phytoestrogen-induced regulatory mechanism. Down-regulation induced by biochanin
A on the levels of ER-α was also observed in MCF-7 cells.
This implies that a response to estradiol in human breast
cancer cells can be decreased upon administration of phytoestrogens.
In response to the estrogen treatment, the level of ER
mRNA was found to decrease by 50% in MCF-7 cells,
which was considered to be an important step on estrogen
action(39). In this study, we investigated whether the effect
of biochanin A was mediated through ER-pathway.
Previous studies have suggested that the phytoestrogens act
via the classical ER dependent pathways. For instance,
Sathyamoorthy et al.(40) showed that phytoestrogen regulate
the expression of the estrogen responsive gene pS2 suggesting an ER-dependent pathway was activated by phytoestrogens. However, there is also other evidence that suggests
that the phytoestrogens might not regulate cell growth
exclusively through the classical ER pathways. Previous
study showed that genistein at the growth-stimulatory concentration (1 µM) also caused a down-regulation of ER
levels(23). Thus, it indicated that down regulation of ER
expression might not be associated with reduced cell
growth. Likewise, although compared to biochanin A,
daidzein has a higher affinity for either ER protein subtype
α or β in vitro(3,20), it is biochanin A that shows the higher
potency in human breast cancer cells and other cancer
cells(21,25,27). Similar observation on other phytoestrogens
was reported. For instance, although genistin binds more
weakly to the ER proteins than does genistein, it regulates
the growth of MCF-7 cells more strongly than genistein(18).
Our present results also found that biochanin A had higher
potency in MCF-7 cells, with an IC50 that was approximately half that of daidzein (Figure 1). Further, we found
that none of the effects induced by biochanin A (i.e. a
reduction in the number of viable cells, a delay in the cell
cycle progression, and a down-regulation of ER-α mRNA)
were blocked by the presence of the “pure” antiestrogen
ICI182,780. Although some of the above discrepancies
might be due in part of different experimental designs and
conditions, our present results strongly suggest that
biochanin A might mediate its growth inhibition through
non-classical ER pathways and that instead of the ligand

binding site on ER-α proteins, a novel target site might be
involved.
The biological efficacy of daidzein, biochanin A and
genistein in combination was studied in human bladder
cancer cells. Combined regimen was found to have a
greater inhibitory effect than any single compound(25). The
growth of tumor cells in mice also found that a mixture of
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Figure 3. The effects of co-administration of two phytoestrogens on
the regulation of MCF-7 cell proliferation. (A) MCF-7 cells were
incubated with daidzein at increasing concentration (0-75 µg/mL)
alone or with biochanin A at 5, 10, 20 or 40 µg/mL for 4 days and the
cell viability was determined by WST-1 assay. (B) MCF-7 cells were
incubated with biochanin A at increasing concentration (0-40 µg/mL)
alone or with daidzein at 5, 10, 25, 50 or 75 µg/mL for 4 days and the
number of viable cells was determined by WST-1 assay. The cell
viability obtained from samples treated with 0.1% DMSO vehicle
only in parallel was designated 100%.
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Figure 4. The effects of daidzein and biochanin A on the cell cycle progression of MCF-7 cells as determined by flow cytometry. The MCF-7 cells
were incubated with daidzein or biochanin A at the concentration of 50 or 40 µg/mL, respectively, for 0-48 hr. The percentage of cells in each cell
cycle phase was determined by flow cytometry (n = 2).

daidzein, biochanin A and genistein was more potent than
genistein alone(25). Verma et al.(26) reported that two plant
products, curcumin and genistein, were able to synergistically inhibit cell growth induced by estrogenic pesticides.
In the present study, the growth inhibitory effect of
biochanin A at 40 µ g/mL enhanced by the presence of
daidzein was also observed (Figure 2A). However, at
growth-stimulatory (5 and 20 µg/mL) and growth-neutral
(20 µ g/mL) concentrations of biochanin A, we did not
detect combinatory synergistic effect between daidzein and
biochanin A. The growth stimulatory effects of biochanin
A appeared to be blocked by daidzein that was present
simultaneously (Figure 2, Figure 3A). The reason for
these observations is not yet clear, but these results suggest
that different mechanisms may be involved in the growth
stimulation and inhibition induced by these phytoestrogens.
Further investigation will be required to identify the precise
mechanisms involved.
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